Pathogenesis of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis and Potential Targets for Biologic Treatment

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|216-223

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 216-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of Tumor Necrosis Factor Receptors on Granulocytes in Patients with Myeloperoxidase Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis

By  

Nephron Clin Pract, Vol. 113, Iss. 3, 2009-08 ,pp. : c222-c233

Karger

Access to resources Recommend Favorite

Serum Levels of BAFF and APRIL in Myeloperoxidase Anti-Neutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis: Association with Disease Activity

By  

Nephron Clin Pract, Vol. 118, Iss. 4, 2011-02 ,pp. : c339-c345

Karger

Access to resources Recommend Favorite

Reduced CD5+CD24hiCD38hi and interleukin‐10+ regulatory B cells in active anti‐neutrophil cytoplasmic autoantibody‐associated vasculitis permit increased circulating autoantibodies

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 180, Iss. 2, 2015-05 ,pp. : 178-188

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3151-3159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Outcome and Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Japan

By  

Nephron Clin Pract, Vol. 115, Iss. 1, 2010-02 ,pp. : c21-c27

Karger

Access to resources Recommend Favorite